Show simple item record

dc.contributor.authorWeedon-Fekjær, Haralden_US
dc.contributor.authorRomundstad, Pål Ren_US
dc.contributor.authorVatten, Lars Jen_US
dc.date.accessioned2014-07-07T17:02:23Z
dc.date.issued2014en_US
dc.identifier.citationWeedon-Fekjær, Harald, Pål R Romundstad, and Lars J Vatten. 2014. “Modern mammography screening and breast cancer mortality: population study.” BMJ : British Medical Journal 348 (1): g3701. doi:10.1136/bmj.g3701. http://dx.doi.org/10.1136/bmj.g3701.en
dc.identifier.issn0959-8138en
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:12406614
dc.description.abstractObjective: To evaluate the effectiveness of contemporary mammography screening using individual information about screening history and breast cancer mortality from public screening programmes. Design: Prospective cohort study of Norwegian women who were followed between 1986 and 2009. Within that period (1995-2005), a national mammography screening programme was gradually implemented, with biennial invitations sent to women aged 50-69 years. Participants: All Norwegian women aged 50-79 between 1986 and 2009. Main outcome measures Multiple Poisson regression analysis was used to estimate breast cancer mortality rate ratios comparing women who were invited to screening (intention to screen) with women who were not invited, with a clear distinction between cases of breast cancer diagnosed before (without potential for screening effect) and after (with potential for screening effect) the first invitation for screening. We took competing causes of death into account by censoring women from further follow-up who died from other causes. Based on the observed mortality reduction combined with the all cause and breast cancer specific mortality in Norway in 2009, we used the CISNET (Cancer Intervention and Surveillance Modeling Network) Stanford simulation model to estimate how many women would need to be invited to biennial mammography screening in the age group 50-69 years to prevent one breast cancer death during their lifetime. Results: During 15 193 034 person years of observation (1986-2009), deaths from breast cancer occurred in 1175 women with a diagnosis after being invited to screening and 8996 women who had not been invited before diagnosis. After adjustment for age, birth cohort, county of residence, and national trends in deaths from breast cancer, the mortality rate ratio associated with being invited to mammography screening was 0.72 (95% confidence interval 0.64 to 0.79). To prevent one death from breast cancer, 368 (95% confidence interval 266 to 508) women would need to be invited to screening. Conclusion: Invitation to modern mammography screening may reduce deaths from breast cancer by about 28%.en
dc.language.isoen_USen
dc.publisherBMJ Publishing Group Ltd.en
dc.relation.isversionofdoi:10.1136/bmj.g3701en
dc.relation.hasversionhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061379/pdf/en
dash.licenseLAAen_US
dc.titleModern mammography screening and breast cancer mortality: population studyen
dc.typeJournal Articleen_US
dc.description.versionVersion of Recorden
dc.relation.journalBMJ : British Medical Journalen
dash.depositing.authorVatten, Lars Jen_US
dc.date.available2014-07-07T17:02:23Z
dc.identifier.doi10.1136/bmj.g3701*
dash.contributor.affiliatedVatten, Lars Johan


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record